Printer Friendly

CYTRX CORPORATION ANNOUNCES THE FORMATION OF VETLIFE(TM)

 CYTRX CORPORATION ANNOUNCES THE FORMATION OF VETLIFE(TM)
 NORCROSS, Ga., Aug. 11 /PRNewswire/ -- CytRx Corporation (NASDAQ: CYTR) announced today the formation of Vetlife, an animal health subsidiary focused on the development and commercialization of its growth promoter technology.
 A search for a company president experienced in the animal health field has also been initiated, and plans are under development to raise capital for the stand-alone unit in 1993.
 The growth promoter, which evolved from the core CytRx copolymer technology, has demonstrated significant potential as a feed additive to enhance growth in large scale poultry studies. Jack J. Luchese, president and chief executive officer of CytRx, said, "The creation of Vetlife as a separate animal health company is an important part of the overall CytRx strategy to maximize shareholder value in our technology, without losing focus in the area of human health." Worldwide exclusive rights to the growth promoter will be licensed to the new company, for all species and all territories. Corporate partnerships may be sought by Vetlife as part of its overall commercialization plan.
 CytRx Corporation is a biopharmaceutical company engaged in the research and development of therapeutics incorporating copolymers. The company is developing pharmaceutical products intended for use in the treatment of vascular, immune system and infectious diseases as well as burns. The company is also developing adjuvants for use in both human and veterinary vaccines and is currently marketing Hunter's TiterMax(R), an important immunoadjuvant for use by the basic research community.
 -0- 8/11/92
 /CONTACT: CytRx Corporation public relations, 404-368-9500/
 (CYTR) CO: CytRx Corporation ST: Georgia IN: MTC SU:


BR-BN -- AT011 -- 9150 08/11/92 17:21 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 11, 1992
Words:273
Previous Article:UNILAB ANNOUNCES SECOND QUARTER RESULTS
Next Article:AMERICAN STOCK EXCHANGE DAILY REPORT
Topics:


Related Articles
CYTRX CORPORATION ANNOUNCES THE FORMATION OF VAXCEL(TM)
CYTRX CORPORATION NAMES PRESIDENT AND CEO FOR VETLIFE INC.
VETLIFE ANNOUNCES NEW VICE PRESIDENT OF RESEARCH AND DEVELOPMENT
Vetlife, Inc. Named Exclusive U.S. Supplier For Compudose Implants
CytRx Corporation Announces 1996 Nine Month Results
VetLife Announces FDA Product Approval
CytRx Corporation Announces 1997 First Quarter Results 520% Increase In Revenues
CytRx Reports Record Revenues
CytRx Corporation Reports Record Revenues
CytRx Reports First Quarter Results

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters